Copyright
©The Author(s) 2017.
World J Crit Care Med. May 4, 2017; 6(2): 116-123
Published online May 4, 2017. doi: 10.5492/wjccm.v6.i2.116
Published online May 4, 2017. doi: 10.5492/wjccm.v6.i2.116
Variable | n = 51 |
Age (yr) | 56 (18-82) |
Gender | |
Female | 27 (53%) |
APACHE II | 15 (7-23) |
ICU LOS (d) | 4 (1-60) |
Operative time (min) | 413 (65-815) |
Primary site | |
Colon | 19 |
Appendix | 12 |
Gastric | 6 |
Ovarian | 3 |
Pseudomyxoma peritoneii | 6 |
Mesothelial | 3 |
Others | 2 |
EBL (mL) | 1125 (50-6500) |
Peritoneal cancer index (intraop) | 13 (3-35) |
Complication | n = 51 |
Acute respiratory failure | 18 (33) |
Postoperative hypovolemia | 51 (100) |
Postoperative hypotension | 13 (25) |
Septic shock | 7 (13) |
Reintubation | 6 (12) |
Acute blood loss anemia | 18 (33) |
Pulmonary embolism | 4 (8) |
Acute renal failure | 5 (10) |
Tracheostomy | 4 (8) |
Dilutional coagulopathy | 28 (55) |
Hypoalbuminemia | 51 (100) |
Arrythmias | 2 (3) |
CLABSI | 0 (0) |
ICU delirium | 3 (6) |
Surgical complications | |
Anastomotic leaks | 8 (15) |
Anastomotic leaks requiring OR | 5 |
Intra abdominal abscess | 5 (10) |
Intra abdominal abscess requiring IR drainage | 4 |
Surgical bleeding | 4 (8) |
Deep wound infection | 4 (8) |
Abdominal sepsis: Anastomotic leak, abscess, deep wound infection | 17 (33) |
Bacteremia | 2 (3) |
Postoperative parenteral nutrition | 9 (18) |
Variable, n (%) | ICU group | Non ICU group | P value |
n = 51 | n =119 | ||
Age, mean (SD) | 56.6 (12.8) | 54.5 (10.5) | 0.282 |
ASA, mean (SD) | 3.1 (0.6) | 2.8 (0.5) | 0.009 |
ASA, > 3 (%) | 12 (24) | 8 (6.7) | < 0.001 |
Intraop PCI, mean (SD) | 21.5 (8.4) | 13.7 (8.3) | < 0.001 |
Change in PCI, mean (SD) | 16.2 (7.1) | 10.7 (6.1) | < 0.001 |
No. of resected organs: Mean (SD) | 5.9 (2.2) | 3.1 (2.1) | < 0.001 |
EBL, mean (SD) | 1505 (1408) | 423 (519) | < 0.001 |
Intraop transfusion (%) | 45 (90) | 26 (21.7) | < 0.001 |
OR time, min, mean (SD) | 456 (122) | 328 (118) | < 0.001 |
Mortality at | |||
30 d (%) | 2 (4) | 2 (1.7) | 0.36 |
90 d (%) | 8 (12) | 6 (5) | 0.104 |
Hospital stay, mean (range) | 18 (5-88) | 8.6 (3-101) | < 0.001 |
Survival, mo: Median (SE) | 14 (1.8) | 33.4 (5.3) | < 0.001 |
Readmission rate to ICU (%) | 6/51 (12) | 3/119 (2.5) | 0.01 |
- Citation: Kapoor S, Bassily-Marcus A, Alba Yunen R, Tabrizian P, Semoin S, Blankush J, Labow D, Oropello J, Manasia A, Kohli-Seth R. Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. World J Crit Care Med 2017; 6(2): 116-123
- URL: https://www.wjgnet.com/2220-3141/full/v6/i2/116.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v6.i2.116